4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-003921
Chief Executive Officer sold 50,000 shares at $36.80 ($1,840,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2023-02-02 | Sale | −50,000 | $36.80 | $1,840,000 | 430,905 | D |
| Open-market sales · 50,000 sh · avg $36.80 · $1,840,000 | |||||||
Loading xslF345X03/doc4.xml…